神州细胞：公司2025年研发投入初步测算在83000万元~87000万元区间

Group 1 - The core viewpoint of the article highlights that the company, ShenZhou Cell, plans to invest approximately 83 million to 87 million yuan in research and development (R&D) by 2025 [2] - The company is currently in a growth phase, and maintaining high R&D investment is essential for its future development, which is a common characteristic among innovative drug development companies [2] - As multiple projects progress into mid-to-late clinical research stages, the company's R&D expenditures are expected to remain elevated [2]